AAV 3.0

Gene therapy assays; gene therapy reagents; gene therapy preparations; nucleic acid delivery assays; nucleic acid delivery reagents; nucleic acid delivery preparations; viral vectors; gene therapy vectors; nucleic acid delivery vectors; cells and tissues transformed by viral vectors, gene therapy vectors, and nucleic acid delivery vectors

Chemical preparations for gene therapy for treating genetic disorders; viral medicines; gene therapy medicines; nucleic acid delivery medicines; viral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of human diseases

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific and medical research and development, namely, laboratory research in the field of gene therapy vectors for medical and research purposes; genetic engineering biotechnology services, namely, research and development of new technology in the field of biotechnology; product development services related to gene therapy products and instruments; consultation services in the fields of medical and scientific research in the field of gene therapy

Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of human diseases